421 related articles for article (PubMed ID: 5548385)
1. [Our first observations on Parkinson's disease or parkinsonian syndromes treated with L-dopa].
Boudouresques J; Khalil R; Vigouroux RA; Gosset A; Daniel F; Dufour H
Mars Med; 1971; 108(2):85-9. PubMed ID: 5548385
[No Abstract] [Full Text] [Related]
2. [Action of L-dopa in Parkinson's syndrome].
Ucar S; Eiras J
Rev Clin Esp; 1971 Feb; 120(3):257-62. PubMed ID: 5568474
[No Abstract] [Full Text] [Related]
3. [L-dopa in Parkinson's syndrome].
Filho RM; de Karam GM
Rev Bras Med; 1971 May; 28(5):220-31. PubMed ID: 5563096
[No Abstract] [Full Text] [Related]
4. [Clinical study of L-dopa in Parkinson's disease].
Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M
Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
[No Abstract] [Full Text] [Related]
5. [Treatment of Parkinson's disease with L-dopa and with a combination of L-dopa and dopa-decarboxylase inhibitor].
Agnoli A; Casacchia M; Reitano M; Ruggieri S; Barba C; Zamponi A
Minerva Med; 1972 Dec; 63(89):4853-61. PubMed ID: 4566743
[No Abstract] [Full Text] [Related]
6. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.
Lewis I
J Med Assoc State Ala; 1971 May; 40(11):709-18. PubMed ID: 5573008
[No Abstract] [Full Text] [Related]
7. [L-Dopa therapy in Parkinson's disease. A double-blind study].
Worm-Petersen J; Dupont E; Mikkelsen B
Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
[No Abstract] [Full Text] [Related]
8. [Preliminary impressions of the therapeutic effectiveness of L-dopa in Parkinson's disease].
Buscaino GA; Campanella G
Sist Nerv; 1970; 22(2):82-91. PubMed ID: 5504561
[No Abstract] [Full Text] [Related]
9. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome].
Lombardo L
Arch Invest Med (Mex); 1973; 4(3):215-24. PubMed ID: 4784173
[No Abstract] [Full Text] [Related]
10. Preliminary observations on L-dopa in the treatment of Parkinson's disease.
Jelsma F; Roth R; Ross P; Davis J
J Ky Med Assoc; 1971 Apr; 69(4):265-9. PubMed ID: 5577419
[No Abstract] [Full Text] [Related]
11. L-dopa and amantadine hydrochloride in Parkinson's disease.
Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
[No Abstract] [Full Text] [Related]
12. [Treatment of Parkinson's syndrome with L-dopa. In operated and nonoperated cases].
Pimenta Ada M; Friguglietti DJ
Rev Bras Med; 1971 Sep; 28(9):481-96. PubMed ID: 5139650
[No Abstract] [Full Text] [Related]
13. [Study of 30 parkinsonian patients treated for 6 months with L-Dopa].
Barbizet J; Duizabo P
Therapie; 1972; 27(1):133-40. PubMed ID: 5017549
[No Abstract] [Full Text] [Related]
14. [L-dopa therapy of Parkinson's syndrome. Comparison of pure L-dopa and the combination preparation L-dopa and decarboxylase inhibitor].
Görlich J; Markus E
Dtsch Med Wochenschr; 1972 Aug; 97(34):1246-8. PubMed ID: 5048316
[No Abstract] [Full Text] [Related]
15. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
Ferel D
Schweiz Med Wochenschr; 1972 Jan; 102(3):88-94. PubMed ID: 4551909
[No Abstract] [Full Text] [Related]
16. [L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases)].
Mazza C; Buffatti PF; Bazzan A; Lion P
Fracastoro; 1970; 63(5):768-73. PubMed ID: 5519378
[No Abstract] [Full Text] [Related]
17. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
Sigwald J; Raymondeaud C; Piot C
Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
[No Abstract] [Full Text] [Related]
18. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y
Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721
[No Abstract] [Full Text] [Related]
19. [Treatment of Parkinson's disease with L-dopa. 77 cases].
Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
[No Abstract] [Full Text] [Related]
20. [Silent period in patients with Parkinson's disease treated with L-Dopa].
Palao Sánchez A
Arch Neurobiol (Madr); 1973; 36(1):47-56. PubMed ID: 4706780
[No Abstract] [Full Text] [Related]
[Next] [New Search]
